Table 1 Participant characteristics
Tuberous Sclerosis Complex Participants | Typically developing controls | |
|---|---|---|
N | 49 | 49 |
Age, months, mean(SD) | 22.2 (7.4) | 23.0 (8.1) |
Sex, % male | 51.0% | 51.0% |
Mullen Verbal Developmental Quotient, mean(SD) | 63.2 (23.6) | 117.9 (17.8) |
Mullen Nonverbal Developmental Quotient, mean(SD) | 73.1 (22.1) | 114.8 (14.2) |
Seizures | ||
% current seizures (last 2 months) | 40.8% | |
% on GABA antagonist | 85.7% | |
% infantile spasms: current ⦁ past ⦁ no history of spasms | 8.2 ⦁ 59.2 ⦁ 32.7% | |
Number of seizure medications | 2.4 (1.4) | |
Surgery | 8.2% | |